Télécharger le texte intégral

References
1. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C Virus prevalence among
patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the
US adult AIDS Clinical Trials Group. Clin Infect Dis 2002;34:831-837.
2. Salmon-Ceron D, Lewden C, Morlat P, Bevilacqua S, Jougla E, Bonnet F, et al. Liver
disease as a major cause of death among HIV infected patients: role of hepatitis C and B
viruses and alcohol. J Hepatol 2005;42(6):799-805.
3. Moore RD, Gebo KA, Lucas GM, Keruly JC. Rate of comorbidities not related to HIV
infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status.
Clin Infect Dis 2008;47(8):1102-4.
4. Rosenthal E, Salmon-Ceron D, Lewden C, Bouteloup V, Pialoux G, Bonnet F, et al. Liverrelated
deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC
Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalite 2005
survey, ANRS EN19). HIV Med 2009;10(5):282-9.
5. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver
fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected
patients. The Multivirc Group. Hepatology 1999;30(4):1054-8.
6. Mohsen AH, Easterbrook PJ, Taylor C, Portmann B, Kulasegaram R, Murad S, et al.
Impact of human immunodeficiency virus (HIV) infection on the progression of liver
fibrosis in hepatitis C virus infected patients. Gut 2003;52:1035-1040.
7. Martin-Carbonero L, Benhamou Y, Puoti M, Berenguer J, Mallolas J, Quereda C, et al.
Incidence and predictors of severe liver fibrosis in human immunodeficiency virusinfected
patients with chronic hepatitis C: a European collaborative study. Clin Infect Dis
2004;38:128-133.
8. Bravo AA, Sheth SG, S C. Liver biopsy. N Engl J Med 2001;344:495-500.
9. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis
C. Hepatology 2003;38:1449-1457.
10. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling
error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am
J Gastroenterol 2002;97:2614-2618.
11. Castera L, Nègre I, Samii K, C. B. Pain experienced during percutaneous liver biopsy.
Hepatology 1999;30:1529-1530.
12. Cadranel JF, Rufat P, F D. Practices of liver biopsy in France: results of a prospective
nationwide survey. For the Group of Epidemiology of the French Association for the
Study of the Liver (AFEF). Hepatology 2000; 32:477-481.
20